SEC Form 4 · accession 0001209191-19-001520
Odonate Therapeutics, Inc. · ODT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Johnson
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 8:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $14.08 | Dec 31, 2018 | A | 12,500 | A | — | Dec 31, 2028 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The stock options vest and become exercisable on December 31, 2019, subject to the Reporting Person's continued service to the Issuer through such date.